Cost-effectiveness analysis of antiretroviral therapy in a cohort of HIV-infected patients starting first-line highly active antiretroviral therapy during 6 years of observation

OBJECTIVES: Costs may play a role in deciding how and when to start highly active antiretroviral therapy (HAART) in a naïve patient. The aim of the present study was to assess the cost- effectiveness of treatment with HAART in a large clinical cohort of naïve adults to determine the potential role o...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Patient Relat Outcome Meas
Prif Awduron: Maggiolo, Franco, Colombo, Giorgio L, Di Matteo, Sergio, Bruno, Giacomo M, Astuti, Noemi, Di Filippo, Elisa, Masini, Giulia, Bernardini, Claudia
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Dove Medical Press 2015
Pynciau:
Original Research
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4337626/
https://ncbi.nlm.nih.gov/pubmed/25733942
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/PROM.S63586
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg